Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05570448 · ClinicalTrials.gov registry record · NA
Anti-Reflux Endoscopic TX Using APC (AREA) in GERD Patients: (The AREA Study)
A NA study of Gastroesophageal Reflux, sponsored by Midwest Veterans' Biomedical Research Foundation.
- Recruiting
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT05570448: Recruiting NA study of Gastroesophageal Reflux, sponsored by Midwest Veterans' Biomedical Research Foundation.
NCT05570448 is a NA study of Gastroesophageal Reflux that is actively recruiting participants, run by Midwest Veterans' Biomedical Research Foundation. The registered enrollment target is 36 participants, below the 2,885-participant average among 33 other Gastroesophageal Reflux trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05570448, a NA study of Gastroesophageal Reflux, is actively recruiting participants, sponsored by Midwest Veterans' Biomedical Research Foundation.
- RECRUITING
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
This will be a randomized clinical trial examining the efficacy and safety of ARAT (intervention group) in patients with chronic GERD symptoms (typical symptoms of GERD, i.e. heartburn or acid reflux/regurgitation at least twice a week) for the last 6 months. Patients must have a positive pH test and a negative manometry (no treatment) procedure.
Primary Outcome
The primary outcome of quality of life will be measured using the validated GERD related quality of life questionnaire (GERD-HRQL). The total score is 50, and a higher score is associated with more severe symptoms.
Conditions Studied
Interventions
- PROCEDURE ARAT
- PROCEDURE Sham intervention (control)
Study Locations (1)
Missouri
- Kansas City VA Hospital - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2022-02-15 |
| Est. Completion | 2027-04-01 |
| Phase | NA |
What NCT05570448 shows while recruiting
NCT05570448 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 2,885-participant average among 33 other Gastroesophageal Reflux trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Gastroesophageal Reflux appearing as the primary indexed condition, and to 2 interventions - of which ARAT is the first listed.
NCT05570448 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT05570448 about?
NCT05570448 is a clinical study titled "Anti-Reflux Endoscopic TX Using APC (AREA) in GERD Patients: (The AREA Study)". This will be a randomized clinical trial examining the efficacy and safety of ARAT (intervention group) in patients with chronic GERD symptoms (typical symptoms of GERD, i.e. heartburn or acid reflux/regurgitation at least twice a week) for the last 6 months. Patients must have a positive pH test a...
What is the current status of trial NCT05570448?
This trial is currently recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2022-02-15. Estimated completion is 2027-04-01.
What conditions does trial NCT05570448 study?
This clinical trial studies the following conditions: Gastroesophageal Reflux.
What interventions are being tested in trial NCT05570448?
The interventions under investigation include: ARAT (PROCEDURE), Sham intervention (control) (PROCEDURE).
Who is sponsoring clinical trial NCT05570448?
This trial is sponsored by Midwest Veterans' Biomedical Research Foundation, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05570448 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastroesophageal Reflux
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05570448's enrollment target sits among peer trials
36 29th of 33 higher than 5 of 33 other Gastroesophageal Reflux trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gastroesophageal Reflux trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of Breath Testing for Small Intestinal Bacterial Overgrowth
RECRUITING · NA
-
Transpyloric Versus Gastric Feeding in Bronchopulmonary Dysplasia
RECRUITING · NA
-
Compassionate Use of Domperidone for Refractory Gastroparesis
RECRUITING · NA
-
External UES Band (Shaker Pressure Band) and GERD
RECRUITING · NA
-
Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms
RECRUITING · NA
-
Establishing Pressures at the EGJ During Diaphragmatic Breathing Using High-resolution Esophageal Manometry
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI